Free Trial

Cyclacel Pharmaceuticals (CYCC) News Today

Cyclacel Pharmaceuticals logo
$7.36 -0.33 (-4.23%)
As of 01:33 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CYCC Latest News

Cyclacel Pharmaceuticals, Inc. (CYCCP) - Yahoo Finance
Cyclacel Pharmaceuticals Announces Stock Split
Cyclacel (CYCC) Share News Today - Investing.com UK
CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT
Cyclacel Pharmaceuticals Restructures Leadership and Financial Strategy
Cyclacel announces agreement for acquisition of preferred stock
Cyclacel Pharmaceuticals Reports Q3 2024 Financial Results
Cyclacel Pharmaceuticals granted extension for regain Nasdaq compliance
Get Cyclacel Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYCC and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CYCC Media Mentions By Week

CYCC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CYCC
News Sentiment

1.00

0.69

Average
Medical
News Sentiment

CYCC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CYCC Articles
This Week

1

1

CYCC Articles
Average Week

Get the Latest News and Ratings for CYCC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:CYCC) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners